BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17869517)

  • 1. Protein O-mannosyltransferase activities in lymphoblasts from patients with alpha-dystroglycanopathies.
    Manya H; Bouchet C; Yanagisawa A; Vuillaumier-Barrot S; Quijano-Roy S; Suzuki Y; Maugenre S; Richard P; Inazu T; Merlini L; Romero NB; Leturcq F; Bezier I; Topaloglu H; Estournet B; Seta N; Endo T; Guicheney P
    Neuromuscul Disord; 2008 Jan; 18(1):45-51. PubMed ID: 17869517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of enzyme activity and clinical phenotype in POMT1-associated dystroglycanopathies.
    Lommel M; Cirak S; Willer T; Hermann R; Uyanik G; van Bokhoven H; Körner C; Voit T; Barić I; Hehr U; Strahl S
    Neurology; 2010 Jan; 74(2):157-64. PubMed ID: 20065251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. POMGnT1, POMT1, and POMT2 mutations in congenital muscular dystrophies.
    Endo T; Manya H; Seta N; Guicheney P
    Methods Enzymol; 2010; 479():343-52. PubMed ID: 20816175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation.
    Yanagisawa A; Bouchet C; Van den Bergh PY; Cuisset JM; Viollet L; Leturcq F; Romero NB; Quijano-Roy S; Fardeau M; Seta N; Guicheney P
    Neurology; 2007 Sep; 69(12):1254-60. PubMed ID: 17634419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and etiology of congenital muscular dystrophy.
    Peat RA; Smith JM; Compton AG; Baker NL; Pace RA; Burkin DJ; Kaufman SJ; Lamandé SR; North KN
    Neurology; 2008 Jul; 71(5):312-21. PubMed ID: 18160674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity.
    Manya H; Chiba A; Yoshida A; Wang X; Chiba Y; Jigami Y; Margolis RU; Endo T
    Proc Natl Acad Sci U S A; 2004 Jan; 101(2):500-5. PubMed ID: 14699049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POMT2 intragenic deletions and splicing abnormalities causing congenital muscular dystrophy with mental retardation.
    Yanagisawa A; Bouchet C; Quijano-Roy S; Vuillaumier-Barrot S; Clarke N; Odent S; Rodriguez D; Romero NB; Osawa M; Endo T; Taratuto AL; Seta N; Guicheney P
    Eur J Med Genet; 2009; 52(4):201-6. PubMed ID: 19138766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carriers and patients with muscle-eye-brain disease can be rapidly diagnosed by enzymatic analysis of fibroblasts and lymphoblasts.
    Vajsar J; Zhang W; Dobyns WB; Biggar D; Holden KR; Hawkins C; Ray P; Olney AH; Burson CM; Srivastava AK; Schachter H
    Neuromuscul Disord; 2006 Feb; 16(2):132-6. PubMed ID: 16427280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin.
    Yamamoto T; Kato Y; Kawaguchi M; Shibata N; Kobayashi M
    Med Electron Microsc; 2004 Dec; 37(4):200-7. PubMed ID: 15614444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the POMT1 gene found in patients with Walker-Warburg syndrome lead to a defect of protein O-mannosylation.
    Akasaka-Manya K; Manya H; Endo T
    Biochem Biophys Res Commun; 2004 Dec; 325(1):75-9. PubMed ID: 15522202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome.
    van Reeuwijk J; Janssen M; van den Elzen C; Beltran-Valero de Bernabé D; Sabatelli P; Merlini L; Boon M; Scheffer H; Brockington M; Muntoni F; Huynen MA; Verrips A; Walsh CA; Barth PG; Brunner HG; van Bokhoven H
    J Med Genet; 2005 Dec; 42(12):907-12. PubMed ID: 15894594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-mannosylation in mammalian cells.
    Endo T; Manya H
    Methods Mol Biol; 2006; 347():43-56. PubMed ID: 17072003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystroglycanopathy with two novel POMT1 mutations in a Chinese boy with developmental delay and muscular dystrophy.
    Chong YK; Ma LC; Lo KL; Lee CK; Mak CM; Kan AN; Lam CW
    Eur J Paediatr Neurol; 2014 Jul; 18(4):532-5. PubMed ID: 24657014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POMT2, a key enzyme in Walker-Warburg syndrome: somatic sPOMT2, but not testis-specific tPOMT2, is crucial for mannosyltransferase activity in vivo.
    Lommel M; Willer T; Strahl S
    Glycobiology; 2008 Aug; 18(8):615-25. PubMed ID: 18490429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
    Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
    Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy].
    Toda T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular heterogeneity in fetal forms of type II lissencephaly.
    Bouchet C; Gonzales M; Vuillaumier-Barrot S; Devisme L; Lebizec C; Alanio E; Bazin A; Bessières-Grattagliano B; Bigi N; Blanchet P; Bonneau D; Bonnières M; Carles D; Delahaye S; Fallet-Bianco C; Figarella-Branger D; Gaillard D; Gasser B; Guimiot F; Joubert M; Laurent N; Liprandi A; Loget P; Marcorelles P; Martinovic J; Menez F; Patrier S; Pelluard-Nehmé F; Perez MJ; Rouleau-Dubois C; Triau S; Laquerrière A; Encha-Razavi F; Seta N
    Hum Mutat; 2007 Oct; 28(10):1020-7. PubMed ID: 17559086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle MRI of the lower limbs in congenital muscular dystrophy patients with novel POMT1 and POMT2 mutations.
    Hafner P; Bonati U; Fischmann A; Schneider J; Frank S; Morris-Rosendahl DJ; Dumea A; Heinimann K; Fischer D
    Neuromuscul Disord; 2014 Apr; 24(4):321-4. PubMed ID: 24556424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glyc-O-genetics of Walker-Warburg syndrome.
    van Reeuwijk J; Brunner HG; van Bokhoven H
    Clin Genet; 2005 Apr; 67(4):281-9. PubMed ID: 15733261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan.
    Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I
    Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.